Back
aTyr Pharma, Inc. Stock Predictions
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
52
ATYR
aTyr Pharma, Inc.
Last Price:
$0.83
Seasonality Move:
-2.14%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiaTyr Pharma, Inc. Stock Forecast
-
Is aTyr Pharma, Inc. Stock Undervalued?The current aTyr Pharma, Inc. [ATYR] share price is $0.83. The Score for ATYR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
ATYR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will aTyr Pharma, Inc. Stock Go Up Next Year?
Data Unavailable
aTyr Pharma, Inc. Stock Rating
Data Unavailable
aTyr Pharma, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
atyrpharma.com
52-Week Data
52-Week High:
7.29
52-Week Low:
0.64
Prediction Charts
Market Cap:
81.1M
Price in USD:
0.83
Volume:
3.2M
Beta:
1.52
Technical Analysis
SMA50:
0.84
SMA100:
2.75
SMA200:
3.37
52-Wk Change:
-75.14%
Stock Predictions
-
Is aTyr Pharma, Inc. stock public?Yes, aTyr Pharma, Inc. is a publicly traded company.
-
What is the aTyr Pharma, Inc. stock quote today?The aTyr Pharma, Inc. stock price is 0.83 USD today.
-
How to buy aTyr Pharma, Inc. stock online?You can buy aTyr Pharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 0.69 | 0.75 | 0.75 | 0.69 |
| Nov-17 | 0.74 | 0.68 | 0.77 | 0.68 |
| Nov-18 | 0.69 | 0.70 | 0.72 | 0.68 |
| Nov-19 | 0.70 | 0.68 | 0.72 | 0.67 |
| Nov-20 | 0.69 | 0.65 | 0.72 | 0.65 |
| Nov-21 | 0.64 | 0.66 | 0.69 | 0.64 |
| Nov-24 | 0.66 | 0.78 | 0.78 | 0.65 |
| Nov-25 | 0.76 | 0.77 | 0.79 | 0.74 |
| Nov-26 | 0.77 | 0.77 | 0.80 | 0.74 |
| Nov-28 | 0.77 | 0.78 | 0.80 | 0.76 |
| Dec-1 | 0.77 | 0.74 | 0.81 | 0.74 |
| Dec-2 | 0.74 | 0.71 | 0.75 | 0.71 |
| Dec-3 | 0.71 | 0.77 | 0.77 | 0.70 |
| Dec-4 | 0.77 | 0.83 | 0.86 | 0.75 |
aTyr Pharma, Inc. Earnings
Data Unavailable
aTyr Pharma, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.30 per share.
* aTyr Pharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.